Literature DB >> 17215150

Canine leishmaniasis: a diagnostic and clinical challenge.

Gad Baneth, Itamar Aroch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17215150     DOI： 10.1016/j.tvjl.2006.11.011

Source DB:  PubMed          Journal:  Vet J        ISSN： 1090-0233            Impact factor:   2.688


× No keyword cloud information.
  18 in total

1.  Canine leishmaniasis: the key points for qPCR result interpretation.

Authors:  Verónica Martínez; Javier Quilez; Armand Sanchez; Xavier Roura; Olga Francino; Laura Altet
Journal:  Parasit Vectors       Date:  2011-04-13       Impact factor: 3.876

2.  Semi-quantitative measurement of asymptomatic L. infantum infection and symptomatic visceral leishmaniasis in dogs using Dual-Path Platform® CVL.

Authors:  Mandy Larson; Angela Toepp; Benjamin Scott; Melissa Kurtz; Hailie Fowler; Javan Esfandiari; Randall F Howard; Aarthy C Vallur; Malcolm S Duthie; Christine Petersen
Journal:  Appl Microbiol Biotechnol       Date:  2016-10-31       Impact factor: 4.813

Review 3.  A new Leishmania-specific hypothetical protein and its non-described specific B cell conformational epitope applied in the serodiagnosis of canine visceral leishmaniasis.

Authors:  Daniela P Lage; Vívian T Martins; Mariana C Duarte; Lourena E Costa; Esther Garde; Laura M Dimer; Amanda C S Kursancew; Miguel A Chávez-Fumagalli; Danielle F de Magalhães-Soares; Daniel Menezes-Souza; Bruno M Roatt; Ricardo A Machado-de-Ávila; Manuel Soto; Carlos A P Tavares; Eduardo A F Coelho
Journal:  Parasitol Res       Date:  2016-01-19       Impact factor: 2.289

4.  Detection of Leishmania spp. in Chronic Dermatitis: Retrospective Study in Exposed Horse Populations.

Authors:  Alessia Libera Gazzonis; Giulia Morganti; Ilaria Porcellato; Paola Roccabianca; Giancarlo Avallone; Stefano Gavaudan; Cristina Canonico; Giulia Rigamonti; Chiara Brachelente; Fabrizia Veronesi
Journal:  Pathogens       Date:  2022-05-31

5.  First study on efficacy and tolerability of a new alkylphosphocholine molecule (oleylphosphocholine-OlPC) in the treatment of canine leishmaniosis due to Leishmania infantum.

Authors:  Leticia Hernández; Rosa Gálvez; Ana Montoya; Rocio Checa; Alba Bello; Tom Bosschaerts; Herwig Jansen; Cristina Rupérez; Anny Fortin; Guadalupe Miró
Journal:  Parasitol Res       Date:  2013-11-06       Impact factor: 2.289

6.  Serological and molecular survey of Leishmania parasites in apparently healthy dogs in the West Bank, Palestine.

Authors:  Omar Hamarsheh; Abedalmajeed Nasereddin; Safa Damaj; Samir Sawalha; Hanan Al-Jawabreh; Kifaya Azmi; Ahmad Amro; Suheir Ereqat; Ziad Abdeen; Amer Al-Jawabreh
Journal:  Parasit Vectors       Date:  2012-08-31       Impact factor: 3.876

7.  Genetic control of canine leishmaniasis: genome-wide association study and genomic selection analysis.

Authors:  Javier Quilez; Verónica Martínez; John A Woolliams; Armand Sanchez; Ricardo Pong-Wong; Lorna J Kennedy; Rupert J Quinnell; William E R Ollier; Xavier Roura; Lluís Ferrer; Laura Altet; Olga Francino
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

8.  Are vector-borne pathogen co-infections complicating the clinical presentation in dogs?

Authors:  Anna Sara De Tommasi; Domenico Otranto; Filipe Dantas-Torres; Gioia Capelli; Edward B Breitschwerdt; Donato de Caprariis
Journal:  Parasit Vectors       Date:  2013-04-15       Impact factor: 3.876

9.  Seropositivity rates for agents of canine vector-borne diseases in Spain: a multicentre study.

Authors:  Guadalupe Miró; Ana Montoya; Xavier Roura; Rosa Gálvez; Angel Sainz
Journal:  Parasit Vectors       Date:  2013-04-22       Impact factor: 3.876

10.  Association of pro-inflammatory cytokines and iron regulatory protein 2 (IRP2) with Leishmania burden in canine visceral leishmaniasis.

Authors:  Paulo Ricardo Porfírio do Nascimento; Daniella Regina Arantes Martins; Glória Regina Góis Monteiro; Paula Vivianne Queiroz; Francisco Paulo Freire-Neto; José Wilton Queiroz; Adila Lorena Morais Lima; Selma Maria Bezerra Jeronimo
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.